Back to Directory
Atosiban
Performance & EnduranceOxytocin receptor antagonist used to delay preterm labor.
Key Benefits
- ✓Delays preterm labor
- ✓Reduces uterine contractions
- ✓Tocolytic effects
- ✓Used in pregnancy
- ✓Alternative to other tocolytics
Dosing Information
Dosage Range
Weight-based IV
Frequency
Continuous infusion
Typical Duration
Up to 48 hours
Detailed Protocol
Administered via intravenous infusion in hospital setting. Bolus followed by continuous infusion. Hospital use only during preterm labor episodes.
About Atosiban
Atosiban is a synthetic nonapeptide that competitively inhibits oxytocin receptors in the uterus, reducing uterine contractions. Used to delay preterm labor in pregnant women. Approved in Europe and other countries, not FDA-approved in US.
Research Notes
Approved in Europe and many countries (not FDA-approved). Clinical studies show effectiveness in delaying delivery compared to placebo. Used when preterm labor occurs.
Potential Side Effects
- •Nausea
- •Headache
- •Dizziness
- •Tachycardia
- •Injection site reactions
- •Hospital setting only
Always consult with a healthcare professional before starting any peptide therapy.